This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Jennifer’s study is most widely known for the “kicker” – not only did it improve quality of life, palliativecare was associated with a couple months longer survival. . Areej’s study is remarkably novel in that it is, to our knowledge, the first study of palliativecare during curative treatment. . hint: coping).
Lagging supportive services around social determinants of health and limited access to hospice and palliativecare are driving disparities among rural family caregivers. Family caregivers in rural areas are more likely to experience social determinants of health that negatively affect the provision of palliative and end of life care.
Summary Transcript CME Summary If palliativecare was a drug, one question we would want to know before prescribing it is what dose we should give. On today’s podcast, we talk about finding an evidence-based answer to this dosing question with three leaders in palliativecare: Jennifer Temel , Chris Jones , and Pallavi Kumar.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
2010 
258 
Let's personalize your content